Pharmaceutical Executive-03-01-2008

Industry insiders explain how pharma companies are reorganizing their salesforces in the wake of industry-wide layoffs

UK agency takes the heat for slow evaluations and failing to consider societal benefits of new drugs

Congress is firing plenty of ammunition at pharma companies-and the regulators

New research points to the power of a highly educated sales force, supporting the case for a voluntary educational standard

Pharma companies must quit wasting money and get strategic when mapping out their clinical study strategies

The industry needs credibility with consumers to make a spoonful of risk go down. So how does pharma speak to top concerns?

Roche has always gone its own way with biologics, deals, and new medicines. Now that the rest of industry has caught on, how can Roche stay ahead of its time?

Why Big Pharma can no longer afford to treat patient adherence programs as an afterthought

Defending your brand through search optimization

Electronic pedigree is the future of supply chain security. Those still waiting and seeing might what to stop waiting and start tracking